SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report

Criscuolo, M; Salmanton-García, J; Fracchiolla, N; Dragonetti, G; Khanna, N; Weinbergerová, B; Schönlein, M; Machado, M; Labrador, J; Kolditz, M.
J. investig. allergol. clin. immunol ; 33(3): 225-227, 2023.
Artículo en Inglés | IBECS (España) | ID: ibc-221947

Documentos relacionados

  1. Epidemiology of mastocytosis: a population-based study (Sweden).
  2. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
  3. Clinical characteristics of hematological patients concomitant with COVID-19.
  4. Clinical Characteristics of Coronavirus Disease 2019 in China.
  5. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes.
  6. SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020.
  7. Clinical characteristics of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) patients in Hospital Tengku Ampuan Afzan.
  8. Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis.
  9. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
  10. Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.